Federally-Listed PSOs

Below is a list of PSOs that are currently listed by AHRQ. A health care provider can only obtain the confidentiality and privilege protections of the Patient Safety Act by working with a Federally-listed PSO.

Use the categories on the left to filter the list of PSOs or search a PSO name.

Note: AHRQ updates the PSO information contained within the directories weekly, as needed; changes are made when there are newly listed PSOs and/or when existing information requires revision. Changes that would otherwise be effective on a weekend day or holiday will be effective on the next business day. Information contained in the directories is based on attestations that the PSOs provide. To update PSO contact information, please use the Change of Listing Information form; to update profile information, please go to the PSO PPC Web site.

There are 86 total PSOs listed by AHRQ.

PLEASE NOTE: To search for a PSO by State, use the 2 letter state abbreviation. Example: Kansas = KS

Academic Medical Center (AMC) PSO - P0103
Component of Parent Org(s):
  • Risk Management Foundation of the Harvard Medical Institutions, Inc.
Effective Date and Time of Initial Listing: December 22, 2010 12:01 AM ET
PSO Mailing Address: c/o CRICO/RMF, 1325 Boylston Street, Boston, MA 02215
PSO Phone Number: 617-450-5586
Point of Contact: Joanne Locke
Point of Contact Phone: 617-450-6873
Point of Contact Email: jlocke2@rmf.harvard.edu (link is external)
Two Bona Fide Contract Requirement: Next attestation period is 12/22/2018 through 12/21/2020
Disclosures & Finding: None
Subject to FDA-Regulated Reporting Entity Guidance: No
Anesthesia Quality Institute - P0099
Component of Parent Org(s):
  • American Society of Anesthesiologists
Effective Date and Time of Initial Listing: September 22, 2010 12:01 AM ET
PSO Mailing Address: 1061 American Lane, Schaumburg, IL 60173
PSO Phone Number: 847-268-9192
Point of Contact: Gerard M. Tarafa
Point of Contact Phone: 847-268-9159
Point of Contact Email: g.tarafa@asahq.org (link is external)
Two Bona Fide Contract Requirement: Next attestation period is 09/22/2020 through 09/21/2022
Disclosures & Finding: None
Subject to FDA-Regulated Reporting Entity Guidance: No
Ascension Healthcare Patient Safety Organization - P0111
Component of Parent Org(s):
  • Ascension
Effective Date and Time of Initial Listing: May 11, 2011 12:01 AM ET
PSO Mailing Address: 4600 Edmundson Road, St. Louis, MO 63134
PSO Phone Number: 314-733-8164
Point of Contact: Ruth Eaker
Point of Contact Phone: 314-733-8164
Point of Contact Email: Ruth.Eaker@ascension.org (link is external)
Two Bona Fide Contract Requirement: Next attestation period is 05/11/2019 through 05/10/2021
Disclosures & Finding: None
Subject to FDA-Regulated Reporting Entity Guidance: Yes
CHPSO - P0002
Component of Parent Org(s):
  • California Association of Hospitals and Health Systems (CAHHS)
  • Hospital Quality Institute (HQI)
Effective Date and Time of Initial Listing: November 5, 2008 12:01 AM ET
PSO Mailing Address: 1215 K Street, Suite 800, Sacramento, CA 95814
PSO Phone Number: (916) 552-2600
Point of Contact: Barbara Abeling PhD, MS, RN
Point of Contact Phone: 916-552-7614
Point of Contact Email: babeling@chpso.org (link is external)
Two Bona Fide Contract Requirement: Next attestation period is 11/05/2020 through 11/04/2022
Disclosures & Finding: None
Subject to FDA-Regulated Reporting Entity Guidance: No
CHS PSO, LLC - P0122
Component of Parent Org(s):
  • CHS/Community Health Systems, Inc.
Effective Date and Time of Initial Listing: January 11, 2012 12:01 AM ET
PSO Mailing Address: 4000 Meridian Boulevard, Franklin, TN 37067
PSO Phone Number: (615) 465-7000
Point of Contact: Terrie Van Buren RN, BSN, MBA, CPPS
Point of Contact Phone: 615-465-7518
Point of Contact Email: terrie_vanburen@chs.net (link is external)
Two Bona Fide Contract Requirement: Next attestation period is 01/11/2020 through 01/10/2022
Disclosures & Finding: None
Subject to FDA-Regulated Reporting Entity Guidance: No
Center for Patient Safety - P0011
Effective Date and Time of Initial Listing: November 5, 2008 12:01 AM ET
PSO Mailing Address: 4215 Philips Farm Rd, Ste 101-A, Columbia, MO 65201
PSO Phone Number: 573-636-1014
Point of Contact: Alexandra Christgen
Point of Contact Phone: (573) 636-1014
Point of Contact Email: achristgen@centerforpatientsafety.org (link is external)
Two Bona Fide Contract Requirement: Next attestation period is 11/05/2018 through 11/04/2020
Disclosures & Finding: None
Child Health Patient Safety Organization, Inc. - P0119
Component of Parent Org(s):
  • National Association of Children's Hospitals (N.A.C.H.)
Effective Date and Time of Initial Listing: October 12, 2011 12:01 AM ET
PSO Mailing Address: 16011 College Blvd, Suite 250, Lenexa, KS 66219
PSO Phone Number: (913) 981-4118
Point of Contact: Barbara Weis
Point of Contact Phone: (913) 981-4117
Point of Contact Email: barbara.weis@childrenshospitals.org (link is external)
Two Bona Fide Contract Requirement: Next attestation period is 10/12/2019 through 10/11/2021
Disclosures & Finding: None
Subject to FDA-Regulated Reporting Entity Guidance: No
Clarity PSO - P0015
Component of Parent Org(s):
  • Clarity Group, Inc.
Effective Date and Time of Initial Listing: November 19, 2008 12:01 AM ET
PSO Mailing Address: 8725 W Higgins Road, Suite 810, Chicago, IL 60631
PSO Phone Number: (773) 867-8066
Point of Contact: Thomas F. Piotrowski
Point of Contact Phone: (773) 867-8066
Point of Contact Email: tpiotrowski@claritypso.com (link is external)
Two Bona Fide Contract Requirement: Next attestation period is 11/19/2018 through 11/18/2020
Disclosures & Finding: None
Subject to FDA-Regulated Reporting Entity Guidance: No
DARTNet Institute Patient Safety Organization - P0176
Component of Parent Org(s):
  • DARTNet Institute
Effective Date and Time of Initial Listing: December 22, 2015 12:01 AM ET
PSO Mailing Address: 12635 East Montview Blvd, Mailbox 5, Aurora, CO 80045
PSO Phone Number: 800-434-0278
Point of Contact: Danica Schrader
Point of Contact Phone: (720) 232-6153
Point of Contact Email: Danica.Schrader@dartnet.info (link is external)
Two Bona Fide Contract Requirement: Next attestation period is 12/22/2019 through 12/21/2021
Disclosures & Finding: None
Subject to FDA-Regulated Reporting Entity Guidance: No
Institute for Safe Medication Practices (ISMP) - P0009
Effective Date and Time of Initial Listing: November 5, 2008 12:01 AM ET
PSO Mailing Address: 200 Lakeside Drive, Suite 200, Horsham, PA 19044
PSO Phone Number: (215) 947-7797
Point of Contact: Ann D. Shastay RN, MSN, AOCN
Point of Contact Phone: (215) 947-7797
Point of Contact Email: ashastay@ismp.org (link is external)
Two Bona Fide Contract Requirement: Next attestation period is 11/05/2020 through 11/04/2022
Disclosures & Finding: None
Louisiana Alliance for Patient Safety PSO - P0186
Component of Parent Org(s):
  • Louisiana Hospital Association
Effective Date and Time of Initial Listing: November 8, 2016 12:01 AM ET
PSO Mailing Address: 9521 Brookline Ave, Baton Rouge, LA 70809
PSO Phone Number: 225-928-0026
Point of Contact: Floyd J. Roberts Jr., MD, FACP, FCCP
Point of Contact Phone: 225-928-0026, ext. 206
Point of Contact Email: froberts@lhaonline.org (link is external)
Two Bona Fide Contract Requirement: Next attestation period is 11/08/2020 through 11/07/2022
Disclosures & Finding: None
Subject to FDA-Regulated Reporting Entity Guidance: No
Midwest Alliance for Patient Safety - P0087
Component of Parent Org(s):
  • Illinois Health and Hospital Association
Effective Date and Time of Initial Listing: April 28, 2010 12:01 AM ET
PSO Mailing Address: 1151 East Warrenville Road, Naperville, IL 60566
PSO Phone Number: 630-276-5682
Point of Contact: Carrie Pinasco
Point of Contact Phone: 630-276-5845
Point of Contact Email: cpinasco@team-iha.org (link is external)
Two Bona Fide Contract Requirement: Next attestation period is 04/28/2020 through 04/27/2022
Disclosures & Finding: None
Subject to FDA-Regulated Reporting Entity Guidance: No
PsychSafe (Component PSO of UHS of Delaware, Inc. Behavioral Health Division) - P0075
Component of Parent Org(s):
  • UHS of Delaware, Inc.
Effective Date and Time of Initial Listing: October 7, 2009 12:01 AM ET
PSO Mailing Address: 1000 Health Park Drive, Bldg. 3, Suite 400, Brentwood, TN 37027
PSO Phone Number: 847-993-3115
Point of Contact: Karen E Johnson
Point of Contact Phone: 847-993-3115
Point of Contact Email: karen.johnson@uhsinc.com (link is external)
Two Bona Fide Contract Requirement: Next attestation period is 10/07/2019 through 10/06/2021
Disclosures & Finding: None
Subject to FDA-Regulated Reporting Entity Guidance: No
Select Medical Patient Safety and Quality Institute, LLC - P0199
Component of Parent Org(s):
  • Select Medical Corporation
  • Select Medical Holdings Corporation
Effective Date and Time of Initial Listing: June 13, 2018 12:01 AM ET
PSO Mailing Address: 4714 Gettysburg Road, Mechanicsburg, PA 17055
PSO Phone Number: 717-920-6757
Point of Contact: Joan P. Alverzo PhD, CRRN
Point of Contact Phone: (973) 985-6764
Point of Contact Email: JAlverzo@SMPSQI.com (link is external)
Two Bona Fide Contract Requirement: Next attestation period is 06/13/2018 through 06/12/2020
Disclosures & Finding: None
Subject to FDA-Regulated Reporting Entity Guidance: No
The PSO Advisory, LLC - P0089
Effective Date and Time of Initial Listing: May 5, 2010 12:01 AM ET
PSO Mailing Address: 30 Cargill Rd, Cumberland, RI 02864
PSO Phone Number: (401) 228-7590
Point of Contact: William P Smith RPH, MS
Point of Contact Phone: 401-228-7590
Point of Contact Email: wpsmith@thepsoadvisory.com (link is external)
Two Bona Fide Contract Requirement: Next attestation period is 05/05/2018 through 05/04/2020
Disclosures & Finding: None
Vizient™ PSO - P0007
Component of Parent Org(s):
  • Vizient Inc
  • Vizient™ Data Services, LLC
Effective Date and Time of Initial Listing: November 5, 2008 12:01 AM ET
PSO Mailing Address: 155 North Wacker Drive, 40th floor, Chicago, IL 60606
PSO Phone Number: 312-775-4100
Point of Contact: Ellen M. Flynn RN, MBA, JD
Point of Contact Phone: (312) 775-4292
Point of Contact Email: Ellen.Flynn@vizientinc.com (link is external)
Two Bona Fide Contract Requirement: Next attestation period is 11/05/2020 through 11/04/2022
Disclosures & Finding: None
Subject to FDA-Regulated Reporting Entity Guidance: No